Answers are grounded in this paper and cite their sources.
The burden of infectious diseases continues to impact healthcare systems worldwide. In fact, access to lab facilities, well-trained specialists, and diagnostics remains very limited in many cases. Point-of-care testing (PoCT) offers a chance to improve early detection, clinical decision making, and disease surveillance by providing fast, affordable and decentralized diagnostics. The development of PoCT technologies highly depends on the physicochemical properties, functional stability, and integrative potential of biosensing materials. In this review, the recent progress in the development of plasmonic nanoparticles, carbon nanomaterials, quantum dots, metal oxides, nanozymes, functional polymers, hydrogels, and two-dimensional materials for infectious disease diagnostics is critically analyzed. The contributions of the listed materials to signal amplification, target recognition, transduction efficiency, and sensor performance are considered. Their use in paper-based assays, wearable sensors, microfluidic cartridges, low-instrument diagnostics, and smartphone-assisted diagnostic tools is discussed. Representative examples of infectious disease diagnostics employing the described materials are provided. The important aspects of translational research, including reproducibility of analytical measurements, material stability, manufacturability, cost-effectiveness, and practical performance, are considered. The link between materials engineering advances and the requirements of diagnostics and its implementation is made.
No takes yet. Share an insight, caveat, or question.
Agrawal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: